The purpose of this study is to evaluate the hypothesis that in middle-aged, asymptomatic,
adult children of persons with Alzheimer's disease (AD), atorvastatin therapy will
beneficially affect mechanisms thought to contribute to AD risk by improving blood flow in
the brain, improving cerebral perfusion, increasing brain activity patterns, and improving
blood vessel function.